13F HOLDINGS REPORT
Stonepine Capital Management, LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0000935836-24-000386
Total Value
$126.1M
Positions
20
Other Managers
0
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | EVOLUS INC | EOLS | 2,674,356 | $37.4M | 29.70% |
| 2 | ADMA BIOLOGICS INC | ADMA | 3,426,882 | $22.6M | 17.94% |
| 3 | ALIMERA SCIENCES INC | 016259202 | 4,051,072 | $15.8M | 12.53% |
| 4 | GALAPAGOS NV-SPON ADR | GLPGF | 393,634 | $12.7M | 10.05% |
| 5 | REVANCE THERAPEUTICS INC | 761330109 | 1,976,342 | $9.7M | 7.71% |
| 6 | XOMA CORP | XOMAP | 253,770 | $6.1M | 4.84% |
| 7 | TELA BIO INC | TELA | 688,200 | $3.9M | 3.10% |
| 8 | NEKTAR THERAPEUTICS | NKTR | 3,480,409 | $3.3M | 2.58% |
| 9 | MILESTONE PHARMACEUTICALS IN | MIST | 1,462,296 | $2.6M | 2.08% |
| 10 | SCPHARMACEUTICALS INC | 810648105 | 446,776 | $2.2M | 1.78% |
| 11 | CALCIMEDICA INC | CALC | 522,602 | $2.2M | 1.72% |
| 12 | ANIKA THERAPEUTICS INC | ANIK | 60,949 | $1.5M | 1.23% |
| 13 | RIGEL PHARMACEUTICALS INC | RIGL | 1,040,241 | $1.5M | 1.22% |
| 14 | AYTU BIOPHARMA INC | AYTU | 472,469 | $1.4M | 1.14% |
| 15 | XERIS BIOPHARMA HOLDINGS INC | XERS | 598,086 | $1.3M | 1.05% |
| 16 | EXAGEN INC | XGN | 384,600 | $611,514 | 0.49% |
| 17 | ADICET BIO INC | ACET | 141,548 | $332,638 | 0.26% |
| 18 | REZOLUTE INC | RZLT | 121,479 | $309,771 | 0.25% |
| 19 | IO BIOTECH INC | IOBT | 156,167 | $270,169 | 0.21% |
| 20 | SCYNEXIS INC | SCYX | 95,637 | $140,586 | 0.11% |